OCLN and metabolic dysfunction-associated steatotic liver disease: Cilostazol also increased the expression of Claudin-1, Occludin, and ZO-1 related to tight junctions in the colon tissue and improved the intestinal structural integrity of the NAFLD mice, thereby avoiding intestinal microorganisms and their harmful products entering the hepatic portal vein to cause liver disease.